KRAS and cancer: We recently showed that TRAIL signaling via TRAIL-R2 promotes invasion and metastasis of KRAS-mutated cancers by activating Rac1/phosphatidylinositol 3-kinase (PI3K) signaling (von Karstedt et al., 2015).